Literature DB >> 24938693

Aluminum transfer during dialysis: a systematic review.

Joëlle Mardini1, Valery Lavergne, Marc Ghannoum.   

Abstract

PURPOSE: Dialysis-dependent patients are particularly susceptible to the toxic effects of aluminum (Al) because of their impaired ability to eliminate it. Al contamination of dialysis fluid remains a threat in this population. The mechanism for Al diffusion across dialysis membranes is not well established. Our objective is to verify, in AL-exposed patients, the postulate that the direction of Al transfer is predicted by the concentration gradient between free diffusible plasma Al and dialysate Al.
METHODS: A systematic review of the literature was performed. Only papers which included Al plasma concentration ([Al]p), Al dialysate concentration ([Al]d) and direction of Al transfer (positive = from dialysate to plasma, negative = from plasma to dialysate) were selected. We also included four patients from our own cohort. Assuming that [Al]p has an ultrafiltrable fraction between 17 and 23%, cases were considered in keeping with our hypothesis if any of the following scenarios was present: negative Al transfer when [Al]d < [Al]p*23% and positive Al transfer when [Al]d > [Al]p*17%.
RESULTS: The search yielded 409 articles, of which 12 were selected for review. When reviewing individual patients for analysis, 108 out of 115 (94%) patients followed our hypothesis. By further excluding cases in which Al transfer could not be determined, only three out of 111 patients were contrary to out hypothesis.
CONCLUSION: Comparing ultrafiltrable Al to dialysate Al permits to accurately predict the direction of Al transfer. The optimal [Al]d should be <20% of the maximally acceptable [Al]p. In order to follow K/DOQI guidelines ([Al]p < 20 μg/L), the [Al]d should therefore not exceed 4 μg/L. At the level presently supported by K/DOQI ([Al]d < 10 μg/L), [Al]p could realistically reach 50 μg/L and potentially cause toxicity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24938693     DOI: 10.1007/s11255-014-0752-8

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  38 in total

1.  Three deaths associated with excess aluminum in dialysate.

Authors: 
Journal:  Nephrol News Issues       Date:  1992-07

2.  Aluminum transport and dialysance during haemodialysis.

Authors:  S Hosokawa; H Nishitani; T Nishio; T Imai; Y Tomita; T Tomoyoshi; K Sawanishi; O Yoshida
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

Review 3.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

4.  Aluminum toxicokinetics in peritoneal dialysis patients.

Authors:  Corinne Seng Yue; Megan Christie; Valery Lavergne; Tabo Sikaneta; Hulya Taskapan; Karine Mardini; Paul Tam; Robert Ting; Marc Ghannoum
Journal:  Clin Toxicol (Phila)       Date:  2011-08-08       Impact factor: 4.467

5.  Value of serum aluminium monitoring in dialysis patients: a multicentre study.

Authors:  P C D'Haese; J P Clement; M M Elseviers; L V Lamberts; F L Van de Vyver; W J Visser; M E De Broe
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

6.  Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.

Authors:  R Swartz; J Dombrouski; M Burnatowska-Hledin; G Mayor
Journal:  Am J Kidney Dis       Date:  1987-03       Impact factor: 8.860

7.  Is serum aluminium monitoring useful in evaluating aluminium intoxication?

Authors:  P Gilli; F Malacarne; F Fagioli
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

8.  Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis.

Authors:  A C Alfrey; J M Mishell; J Burks; S R Contiguglia; H Rudolph; E Lewin; J H Holmes
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

9.  Aluminum removal by hemodialysis.

Authors:  H Graf; H K Stummvoll; V Meisinger; J Kovarik; A Wolf; W F Pinggera
Journal:  Kidney Int       Date:  1981-04       Impact factor: 10.612

Review 10.  Aluminium intoxication in renal disease.

Authors:  D N Kerr; M K Ward; H A Ellis; W Simpson; I S Parkinson
Journal:  Ciba Found Symp       Date:  1992
View more
  4 in total

Review 1.  The Health Effects of Aluminum Exposure.

Authors:  Katrin Klotz; Wobbeke Weistenhöfer; Frauke Neff; Andrea Hartwig; Christoph van Thriel; Hans Drexler
Journal:  Dtsch Arztebl Int       Date:  2017-09-29       Impact factor: 5.594

2.  Aluminum in Neurological and Neurodegenerative Disease.

Authors:  Donald R C McLachlan; Catherine Bergeron; Peter N Alexandrov; William J Walsh; Aileen I Pogue; Maire E Percy; Theodore P A Kruck; Zhide Fang; Nathan M Sharfman; Vivian Jaber; Yuhai Zhao; Wenhong Li; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2019-01-31       Impact factor: 5.590

3.  Expression of DnMTs and MBDs in AlCl3-Induced Neurotoxicity Mouse Model.

Authors:  Muhammad Faisal Ikram; Syeda Mehpara Farhat; Aamra Mahboob; Saeeda Baig; Ahmed Yaqinuddin; Touqeer Ahmed
Journal:  Biol Trace Elem Res       Date:  2020-11-11       Impact factor: 3.738

4.  Aluminum in neurological disease - a 36 year multicenter study.

Authors:  Walter J Lukiw; Theodore P A Kruck; Maire E Percy; Aileen I Pogue; Peter N Alexandrov; William J Walsh; Nathan M Sharfman; Vivian R Jaber; Yuhai Zhao; Wenhong Li; Catherine Bergeron; Frank Culicchia; Zhide Fang; Donald R C McLachlan
Journal:  J Alzheimers Dis Parkinsonism       Date:  2018-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.